New York TimesImportant note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


AIDS Patients Losing Money For Drugs

The New York Times - Friday, December 1, 1995
Pam Belluck


Low-income people with the AIDS virus will no longer get state money to pay for most painkillers, antibiotics, vitamins and psychotropic drugs, the New York State Department of Health said yesterday.

Starting next year, the state will stop paying for about 70 percent of the drugs used by more than 10,000 uninsured and underinsured people receiving medication and home health care under its H.I.V. Uninsured Care Programs.

Diane Mathis, a spokeswoman for the Health Department, said the cutbacks were necessary because the program, financed mostly by so-called Ryan White funds from the Federal Government, did not have enough money to cover the increasing numbers of people with AIDS or the virus that causes the disease.

Ms. Mathis said the state had chosen to stop paying for 129 medications it considered "nonessential drugs that don't pertain specifically to AIDS patients." The state will continue financing drugs that directly treat AIDS, like AZT.

AIDS advocates said the cuts would severely hurt many people with the virus. They said those in the program are not poor enough to qualify for Medicaid -- which would pay for the medications -- yet they do not earn enough to buy the drugs.

"This diminishing of the program has struck fear in just about every person with AIDS in New York City," said Dennis deLeon, president of the Latino Commission on AIDS, which represents 35 organizations. "Pain is a very serious problem for people with AIDS. Mental illness is a huge factor. With the antibiotics disappearing, some of the infections might start sooner."

State Senator Catherine M. Abate of Manhattan, who represents Greenwich Village, wrote to the Health Commissioner, Dr. Barbara A. DeBuono, yesterday protesting the cuts and asking the state to find money for the drugs.

But Ms. Mathis held out no hope that the state would be able to find the $8.4 million needed to pay for the drugs. She said the "essential" AIDS drugs took every penny of the $44 million the Federal Government provided the state. Ms. Mathis said the department would try to help AIDS patients get free drugs from pharmaceutical companies or "spend down" their assets so they could qualify for Medicaid.

951201
NYT951201


Copyright © 1995 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, the Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .